Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2021.0308

Mini-Review

Developing new clinical predictions to optimize colorectal cancer treatment.

A. Encke, MD, PhD.

 

Abstract
The development of non-invasive screening for early diagnosis as well as clinical predictors to guide personalized effective targeted therapy could substantially improve oncological outcomes of patients with colorectal cancer (CRC). In this review it is discussed the potential increase of current early diagnosis rate of 40% with colonoscopy [1] to over 90% sensitivity rates with whole genome sequencing of circulating cell-free DNA robust analysis with artificial intelligence as a screening tool [2]. Moreover, multi-regional intratumor heterogeneity and matched circulating cell-free DNA mutational land scape identification with Next generation sequencing could be used as clinical predictors to select effective targeted drugs for meaningful treatment of individual patients [3-5].

(Citation: Gastric & Breast Cancer 2021; 16(1): 72-78)

Back
You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €35 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 1 January 2021